"吸必擴"都保定量粉狀吸入劑 320/9 μG/DOSE

Nazione: Taiwan

Lingua: cinese

Fonte: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Principio attivo:

BUDESONIDE;;FORMOTEROL FUMARATE DIHYDRATE

Commercializzato da:

臺灣阿斯特捷利康股份有限公司 台北市大安區敦化南路二段207號21樓 (16440975)

Codice ATC:

R03AK07

Forma farmaceutica:

粉狀吸入劑

Composizione:

FORMOTEROL FUMARATE DIHYDRATE (1216003030) MCG; BUDESONIDE (8406002100) MCG

Confezione:

瓶裝

Classe:

製　劑

Tipo di ricetta:

須由醫師處方使用

Prodotto da:

ASTRAZENECA AB SE-151 85 SODERTALJE SWEDEN SE

Area terapeutica:

formoterol and budesonide

Indicazioni terapeutiche:

１.氣喘（Asthma）適合使用類固醇及長效β2 作用劑（β2-agonist）合併治療的支氣管氣喘（Bronchial asthma）。２.慢性阻塞性肺部疾病（COPD）適用於18 歲以上患有慢性阻塞性肺部疾病（COPD），使用氣管擴張劑後之第一秒吐氣量（post-bronchodilator FEV1）少於預測值之70%及已定期使用支氣管擴張劑，而仍有惡化病史的病患之治療。

Dettagli prodotto:

有效日期: 2029/05/11; 英文品名: SYMBICORT TURBUHALER 320/9 μG/DOSE

Data dell'autorizzazione:

2004-05-11

Foglio illustrativo

®
®
320/9 ΜG/DOSE
SYMBICORT
® TURBUHALER
® 320/9 ΜG/DOSE
Budesonide/formoterol
023980
budesonide
320 µg
formoterol
9 µg
Symbicort Turbuhaler 320 µg / 9 µg
budesonide
formoterol
budesonide 400 µg
/
formoterol
12 µg
/
9 µg
/
491 µg
/
Asthma
β
2
β
2
-agonist
Bronchial
asthma
COPD
18
COPD
post-bronchodilator FEV
1
70%
Symbicort Turbuhaler
Symbicort Turbuhaler
/
β
2
18
2
1
2
2
12-17
2
1
Symbicort Turbuhaler
2
Symbicort
Turbuhaler
6
6-11
80/4.5 µg
/
Symbicort Turbuhaler 320/9 µg
/
12
2
1
Symbicort
Turbuhaler
budesonide
formoterol
SYMBICORT TURBUHALER
Symbicort Turbuhaler
•
/
•
•
•
Symbicort Turbuhaler
•
Symbicort Turbuhaler
budesonide
formoterol
Symbicort
Turbuhaler
Symbicort Turbuhaler
Symbicort Turbuhaler
Symbicort Turbuhaler
Symbicort Turbuhaler
Symbicort Turbuhaler
Symb
icort Turbuhaler
pre-bronchodilator FEV
1
50%
post-bronchodilator FEV
1
70% COPD
p a r a d o x i c a l
bronchospasm
Symbicort Turbuhaler
Cushing's syndrome
Cushingo
id
features
psychomotor hyperactivity
budesonide
1
400 µg
800 µg
Symbicort
Symbicort Turbuhaler
budesonide
ketoconazole
itraconozole
ritonavir
CYP3A4
Symbicort Turbuhaler
Formoterol
QTc
β
2
xanthine
β
2
β
2
central serous
chorioretinopathy, CSCR
CSCR
Symbicort Turbuhaler
< 1
/
COPD
COPD
COPD
COPD
COPD
BMI
COPD
CYP450 3A4
itraconazole
ritonavir
budesonide
CYP450 3A4
budesonide
CYP3A4
Symbicort
β
-
Formoterol
Symbicort Turbuhaler
β
-
Quinidine
Disopyramide
Procainamide
Phenothiazines
Terfenadine
MAO
QTc
L-Dopa
L-thyroxine
Oxytocin
β
2
MAO
furazolidone
procarbazine
Halogenated hydrocarbons
β
-
β
2
xathine
Budesonide
formoterol
Symbicort Turbuhaler
budesonide
formoterol
–
Formoterol
Formoterol
budesonide
2000
Symbicort Turbuhaler
Budesonide
Budesonide
formoterol
formoterol
Symbicort Turbuhaler
Symbicort Turbuhaler
Symbicort Turbuhaler
formoterol
budesonide
β
2
budesonide
10% 6%
4%
3% p < 0.001
p < 0.01
budesonide
formoterol
≥
1/10
≥
1/100
< 1/10
≥
1/1000
< 1/100
≥
1/10000
< 1/1000
< 1/10000
QT
COPD
paradoxical
bronchospasm
β
2
AstraZeneca AB